Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × etoposide phosphate × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 4 Sarcoma, Ewing 2 Rhabdoid Tumor 2 Medulloblastoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Ganglioneuroblastoma 2 Ependymoma 2 Brain Neoplasms 2 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pinealoma 1 Osteosarcoma 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Enteropathy-Associated T-Cell Lymphoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Cyclophosphamide 11 pembrolizumab 7 fludarabine 7 fludarabine phosphate 6 Doxorubicin 6 Vinblastine 5 Gemcitabine 5 Filgrastim 5 Dacarbazine 5 Brentuximab Vedotin 5 Bleomycin 5 Nivolumab 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Vincristine 3 Rituximab 3 Prednisone 3 Melphalan 3 Cisplatin 3 pegfilgrastim 2 Whole-Body Irradiation 2 Vinorelbine 2 Thiotepa 2 Tacrolimus 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03407144 2026-02-19

MK-3475-667

Merck Sharp & Dohme LLC

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡